Back to 
Bank of New York Mellon Corp
Bank of New York Mellon Corp
ANTXShowing 1 of 5 quarters
Position history for Bank of New York Mellon Corp's holdings in AN2 THERAPEUTICS INC
Yes. Bank of New York Mellon holds 67,676 shares of ANTX (AN2 Therapeutics), worth $327,552, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$327,552
Current Shares
67,676
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.